Erectile disfunction medical treatment with phosphodiesterase 5 inhibitors (PDE5i) in patients with retinitis pigmentosa and side effects

Arch Ital Urol Androl. 2020 Dec 18;92(4). doi: 10.4081/aiua.2020.4.326.

Abstract

Retinitis pigmentosa represents a heterogeneous group of degenerative hereditary pathologies of the retinal photoceptors, some forms mainly affect the cones and others the rods. The prevalence of the disease is of 1 case per 3000-5000 inhabitants, in 80-90% of cases these are forms with prevalent involvement of the rods (RCD) and in 10-20% of cases of forms with prevalent involvement of the cones (CRD) [...].

Publication types

  • Letter
  • Review

MeSH terms

  • Erectile Dysfunction / complications*
  • Erectile Dysfunction / drug therapy*
  • Humans
  • Male
  • Phosphodiesterase 5 Inhibitors / adverse effects
  • Phosphodiesterase 5 Inhibitors / therapeutic use*
  • Retinitis Pigmentosa / complications*

Substances

  • Phosphodiesterase 5 Inhibitors